# FDA Inspection 1040962 - BioTissue Holdings Inc - February 06, 2018

Source: https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/adf9e664-a7c0-4ef7-a540-5973fcb81967
Source feed: FDA_Inspections

> FDA Inspection 1040962 for BioTissue Holdings Inc on February 06, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1040962
- Company Name: BioTissue Holdings Inc
- Inspection Date: 2018-02-06
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1304322 - 2026-02-18](https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/521aafa6-8d2b-423e-89e1-46e5342a5736)
- [FDA Inspection 1304322 - 2026-02-18](https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/da6e1db7-5d74-41ee-97b5-f28924c45db2)
- [FDA Inspection 1304322 - 2026-02-18](https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/840defc1-f319-429d-b443-a534695bd6d8)
- [FDA Inspection 1304322 - 2026-02-18](https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/21728721-83fb-40cf-9f69-570bde012772)
- [FDA Inspection 1230477 - 2024-03-06](https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/9d5b8e03-80c4-4415-b518-0218ea44dc91)

Company: https://www.keypedia.com/companies/biotissue-holdings-inc/2cac95ce-8ef8-451a-aa9d-4d03238d18d8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d